CHEN-PEI HUNG: Open Payments
NPI 1649549635 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 36 payments from 14 companies in 2025. Trend: 2023 $698 · 2024 $797 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $96 |
| Lundbeck LLC | 4 | $65 |
| Alkermes, Inc. | 2 | $45 |
| Corium, LLC | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Azstarys, VIVITROL, INGREZZA, ABILIFY ASIMTUFII, Quviviq.
Industry payments across AZ — which companies pay providers there.
